Medicare Enrolled
Dr. Douglas Stuart, M.D.
Neurology · Atlanta, GA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Stuart from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Stuart?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Stuart
Dr. Douglas Stuart is a neurology specialist in Atlanta, GA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Stuart performed 1,392 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Stuart received a total of $599,227 from 53 pharmaceutical and/or device companies across 1164 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Stuart is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 23% volume in GA
$599,227 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗1,392
Medicare services
Top 23% in GA for neurology
Not available
Unique patients (not deduplicated)
$88
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
579 | $90 | $137 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
354 | $60 | $95 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
87 | $129 | $189 |
| MRI scan of brain, without contrast A magnetic resonance imaging test of the brain that does not use contrast dye. This procedure creates detailed images of the brain's structure using magnetic fields and radio waves. |
81 | $144 | $257 |
| New patient office visit, complex (60-74 min) | 60 | $155 | $228 |
| MRI of upper spine without contrast An MRI scan of the upper spinal canal that does not use contrast dye. This imaging test uses magnetic fields and radio waves to create detailed pictures of the spine. |
43 | $101 | $298 |
| Limited needle EMG of arm or leg muscles A test that measures the electrical activity in specific muscles of the arm or leg using a needle electrode. This limited study evaluates muscle function in a targeted area. |
37 | $47 | $66 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
37 | $76 | $104 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
33 | $57 | $168 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
21 | $82 | $241 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
17 | $94 | $319 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
17 | $125 | $467 |
| Psychological test administration, first 30 minutes A technician administers psychological or neuropsychological testing for the first 30 minutes. |
15 | $25 | $39 |
| Nerve conduction studies, 5-6 tests A series of 5 to 6 tests that measure how well nerves send electrical signals. The procedure evaluates nerve function and helps identify damage or dysfunction. |
11 | $97 | $160 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$599,227
Total received (2018-2024)
Avg $85,604/year across 7 years
Top 1% in GA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
53
Companies
1,164
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$47,801
2023
$82,914
2022
$78,547
2021
$48,388
2020
$24,182
2019
$150,657
2018
$166,738
Payments by company (2024)
TG Therapeutics, Inc.
$32,206
E.R. Squibb & Sons, L.L.C.
$5,791
Biogen, Inc.
$4,129
Celgene Corporation
$2,919
EMD Serono, Inc.
$558
ABBVIE INC.
$333
Eisai Inc.
$289
Alexion Pharmaceuticals, Inc.
$253
Novartis Pharmaceuticals Corporation
$213
ARGENX US, INC.
$168
UCB, Inc.
$147
Lilly USA, LLC
$119
Amgen Inc.
$93
MDD US Operations, LLC
$92
Neurocrine Biosciences, Inc.
$76
ACADIA Pharmaceuticals Inc
$56
Lundbeck LLC
$43
BANNER LIFE SCIENCES, LLC
$43
Merz Pharmaceuticals, LLC
$38
Teva Pharmaceuticals USA, Inc.
$36
Genentech USA, Inc.
$36
PFIZER INC.
$33
Alnylam Pharmaceuticals Inc.
$28
Mallinckrodt Hospital Products Inc.
$25
Axsome Therapeutics, Inc.
$22
Cycle Pharmaceuticals Inc
$21
CATALYST PHARMACEUTICALS, INC.
$20
Kyowa Kirin, Inc.
$13
Top 3 companies account for 88.1% of 2024 payments
All-time payments by company (2018-2024) ›
Biogen, Inc.
$207,726
E.R. Squibb & Sons, L.L.C.
$82,080
Novartis Pharmaceuticals Corporation
$77,201
Celgene Corporation
$52,514
TG THERAPEUTICS, INC.
$42,043
Genentech USA, Inc.
$42,014
GENZYME CORPORATION
$34,926
TG Therapeutics, Inc.
$32,206
EMD Serono, Inc.
$11,591
Alexion Pharmaceuticals, Inc.
$8,260
Horizon Therapeutics plc
$3,730
ABBVIE INC.
$408
Amgen Inc.
$398
UCB, Inc.
$369
AbbVie Inc.
$367
Eisai Inc.
$311
Neurocrine Biosciences, Inc.
$304
ACADIA Pharmaceuticals Inc
$279
Teva Pharmaceuticals USA, Inc.
$265
Lilly USA, LLC
$228
ARGENX US, INC.
$219
SK Life Science, Inc.
$157
PFIZER INC.
$147
HARMONY BIOSCIENCES LLC
$115
Arbor Pharmaceuticals, Inc.
$100
BANNER LIFE SCIENCES, LLC
$97
Acorda Therapeutics, Inc
$92
MDD US Operations, LLC
$92
IMPEL PHARMACEUTICALS INC.
$90
Lundbeck LLC
$88
Merz Pharmaceuticals, LLC
$87
BOSTON SCIENTIFIC CORPORATION
$83
Mallinckrodt Hospital Products Inc.
$79
Neurelis, Inc.
$65
Supernus Pharmaceuticals, Inc.
$49
Amneal Pharmaceuticals LLC
$46
Harmony Biosciences LLC
$40
Axsome Therapeutics, Inc.
$38
IDORSIA PHARMACEUTICALS US INC
$37
Otsuka America Pharmaceutical, Inc.
$35
Kyowa Kirin, Inc.
$28
Alnylam Pharmaceuticals Inc.
$28
SANOFI-AVENTIS U.S. LLC
$24
EISAI INC.
$23
Cycle Pharmaceuticals Inc
$21
CATALYST PHARMACEUTICALS, INC.
$20
Marinus Pharmaceuticals, Inc.
$20
JAZZ PHARMACEUTICALS INC.
$20
AstraZeneca Pharmaceuticals LP
$19
Greenwich Biosciences, Inc.
$14
ARBOR PHARMACEUTICALS, INC.
$13
Banner Life Sciences, LLC
$12
Impax Laboratories, Inc.
$12
Top 3 companies account for 61.2% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AIMOVIG · AJOVY · AMPYRA · AMVUTTRA · AMYVID · AUBAGIO · AUSTEDO · AVONEX · Aimovig · Austedo XR · BAFIERTAM · BOTOX · BRIUMVI · Briviact · COMIRNATY · EMGALITY · EPIDIOLEX · Epidiolex · FLUMIST QUADRIVALENT · FYCOMPA · Fycompa · GILENYA · General - Pain Management · Gocovri · Horizant · INBRIJA · INGREZZA · KESIMPTA · KISUNLA · LEMTRADA · LYVISPAH · Leqembi · MAVENCLAD · MAYZENT · MS DISEASE STATE · Mavenclad · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nourianz · OCREVUS · Ocrevus · Ocrevus Zunovo · Ongentys · Ozanimod · PANZYGA · PAXLOVID · PIPELINE-MS · QULIPTA · QUVIVIQ · REXULTI · RYTARY · Rebif · Rystiggo · SKYCLARYS · SOLIRIS · Soliris · Sunosi · TECFIDERA · TEFLARO · TROKENDI XR · TYSABRI · Tascenso ODT · Trudhesa · Tysabri · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VRAYLAR · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · WAKIX · Wakix · XCOPRI · Xeomin · ZEPOSIA · ZTALMY · Zilbrysq
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Neurologists in nearby ZIP areas
230
County median income
$91,490
Nearest hospital to ZIP centroid (approximate)
SAINT JOSEPH'S HOSPITAL OF ATLANTA, INC
2.6 mi
2.6 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Stuart is a clinical cardiology specialist, with above-average Medicare volume (top 23% in GA), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Stuart experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Stuart performed 579 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Stuart receive payments from pharmaceutical companies?
Yes. Dr. Stuart received a total of $599,227 from 53 companies across 1,164 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Stuart's costs compare to other neurologists in Atlanta?
Dr. Stuart's average Medicare payment per service is $88. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Stuart) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Atlanta
Browse neurologists in Atlanta ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in GA
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in GA
Which GA neurologists receive the most from drug and device companies.
By company
Biogen, Inc. Payments to Doctors
See all physicians who received payments from Biogen, Inc.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology